NCT01818232View on ClinicalTrials.gov

Study to Determine the Absorption, Metabolism, and Excretion of [14C]LX4211 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Healthy
Interventions
DRUG

[14C]-LX4211

Trial Locations (1)

53704

Lexicon Investigational Site, Madison

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY